![]() |
市場調查報告書
商品編碼
1713233
歐洲再生牙科市場規模及預測 2021 - 2031、區域佔有率、趨勢及成長機會分析報告涵蓋範圍:按產品類型、技術、應用、年齡層、最終用戶和地區Europe Regenerative Dentistry Market Size and Forecast 2021 - 2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Application, Age Group, End User, and Region |
2024 年歐洲再生牙科市場價值為 8.365 億美元,預計到 2031 年將達到 12.696 億美元;預計 2025 年至 2031 年期間的複合年成長率為 6.3%。本報告中提供的歐洲再生牙科市場預測可以幫助該市場的利害關係人規劃他們的成長策略。老齡人口中牙齒疾病的盛行率不斷上升以及對美容牙科的需求不斷增加是推動歐洲再生牙科市場成長的關鍵因素。
組織再生應用的增加
幹細胞療法改變了牙科專業人員處理牙齒和組織再生的方式,特別是對於牙齒嚴重損傷、牙齒脫落或牙周疾病的患者。以下是一些可能帶來市場新趨勢的方法:
牙齒再生和牙髓治療:
牙髓治療,尤其是活髓治療(VPT),是修復牙科的重要組成部分,旨在保持受影響牙齒的活力。在歐洲,牙髓治療技術的教學和應用各不相同:根據 PubMed 的一項歐洲牙科學校調查顯示,92.9% 的學校教授使用硫酸鐵對乳磨牙進行活髓切斷術,這表明在教育環境中對這種材料的偏好。成熟恆牙的 VPT 成功率非常高。根據 Springer Nature Limited 2025 的回顧性研究報告,在 12-24 個月的追蹤期內,使用 iRoot BP Plus 進行牙髓切斷術的成功率為 99%,凸顯了現代材料在牙髓治療中的有效性。研究人員正在探索幹細胞療法來再生受損或流失的牙髓,這對於維持牙齒活力至關重要。在義大利,米蘭大學等機構正在積極研究牙髓幹細胞再生牙髓組織甚至重新長出功能性牙齒的潛力。這項創新可以取代根管治療或拔牙等傳統方法,為患者提供更自然的解決方案。
與研究機構的合作:
根據倫敦大學學院 2025 計劃,再生與精準醫學發現中心計劃是倫敦大學學院 (UCL) 與包括米尼奧大學在內的葡萄牙大學聯盟合作開展的。該中心獲得了 1500 萬歐元的歐盟「地平線 2020」計畫資助,致力於加速臨床應用和促進再生醫學和精準醫學的創新,其總部位於葡萄牙,並在倫敦大學學院設有支持園區。米蘭理工大學是與私人牙科公司合作進行臨床試驗並進一步探索幹細胞在牙齒和組織再生中的應用的大學之一。這種協作環境促進了新療法的發展,並鼓勵將幹細胞技術融入主流牙科實踐。
臨床實施:
義大利的幾家牙科診所已開始將幹細胞療法納入其治療實踐中。例如,博洛尼亞的古列爾莫·馬可尼牙科診所提供再生治療,利用幹細胞作為牙周治療方法的一部分。這些診所處於實施創新治療的前沿,為患者提供管理牙齒和牙齦健康的先進選擇。
骨骼和牙齦再生:
幹細胞也用於再生因老化、疾病或創傷而出現骨質流失的患者的骨組織,尤其是植牙。利用幹細胞進行骨再生有助於提高植入成功率,特別是骨密度不足的患者。義大利的診所,包括米蘭和羅馬的診所,正在採用基於幹細胞的骨移植來促進植入物周圍骨骼的再生。此外,幹細胞療法顯示出牙齦再生的前景。對於嚴重的牙周病,可以使用幹細胞再生牙齦組織,增強牙齦的功能和美觀。
阻礙歐洲合約研究組織市場的因素
牙齒再生治療的高成本是義大利再生牙科市場成長的重大障礙。這些先進的程序包括幹細胞療法、組織工程和牙齒再生技術,由於需要複雜的技術和專業知識,往往很昂貴。結果,許多患者因高昂的費用而卻步,限制了市場擴張的潛力。歐洲的牙齒再生治療費用根據具體治療程序和進行治療的國家而有所不同。以下是平均成本的明細:
義大利植牙的平均費用從 1,100 美元到 2,700 美元不等,具體取決於診所和地點。再生治療,例如骨移植或幹細胞療法,可能會增加費用,由於涉及先進的材料和技術,有時每次手術的費用高達 5,500-10,800 美元。提供這些服務的診所,尤其是在米蘭和羅馬等城市,通常會對再生牙科治療收取高額費用。
在米蘭國際健康中心,一顆牙齒的植入費用可能在 2,200 美元到 2,700 美元之間,而用於牙齒再生的幹細胞療法等再生程序每次治療的費用可能超過 8,700 美元。同樣,位於克利通諾河畔坎佩洛的 Studio Dentistico Cristina Santi 提供再生治療,費用從 4,800 美元到 9,700 美元不等,具體取決於治療的複雜程度。
在歐洲,單顆牙植體的價格通常在 1,100 歐元至 2,180 歐元之間,具體取決於國家。在匈牙利、波蘭和捷克共和國,費用約為 1,100 歐元。在德國,這個價格大約是 1,700 歐元。在英國,平均費用約為 2,180 歐元。
綜合手術,如 All-on-4 植牙,可以替換下顎骨中的所有牙齒,費用在 4,000 歐元至 18,000 歐元之間。總費用取決於植入物的數量和所用材料等因素。
PRP 療法的費用差異很大,通常每次注射的費用在 500 美元到 2,500 美元之間,具體取決於各種因素。
幹細胞治療費用差異很大,從 5,000 美元到 50,000 美元不等,取決於所施用的幹細胞類型、細胞數量、細胞品質、實驗室位置和幹細胞來源等因素。
這些費用對許多患者來說過於高昂,導致一些患者到國外尋求更實惠的治療選擇。例如,土耳其的植牙起價為 500 歐元,與西歐的價格相比,可節省大量費用。這些治療方法費用高昂,為其廣泛應用設置了若干障礙。許多患者難以負擔此類手術的費用,尤其是在沒有全面保險的情況下。此外,如果沒有明確的投資回報,牙醫可能不願意投資昂貴的再生技術,這進一步限制了許多診所採用先進技術,並限制了義大利再生牙科市場的成長。因此,雖然牙科再生治療前景廣闊,但這些治療的高成本仍然是其在歐洲普及和市場擴張的重大障礙。
根據產品類型,歐洲再生牙科市場分為天然生物材料和合成生物材料。 2024 年,天然生物材料在歐洲再生牙科市場佔有較大佔有率。
根據技術,歐洲再生牙科市場分為組織工程、幹細胞治療等。 2024 年,組織工程領域佔據歐洲再生牙科市場的最大佔有率。
在應用方面,歐洲再生牙科市場分為牙周再生、牙髓再生、牙齒重建、骨骼再生等。 2024 年,牙周再生領域佔據歐洲再生牙科市場的最大佔有率。
根據年齡層,市場分為兒童市場和成人市場。 2024 年,成人市場將佔據歐洲再生牙科市場的較大佔有率。
根據最終用戶,市場分為醫院、牙科診所和其他。 2024 年,牙科診所部門佔據歐洲再生牙科市場的最大佔有率。
在撰寫歐洲再生牙科市場報告時參考的一些主要一手和二手資料來源包括 Geistlich Pharma AG、Evonik Industries AG、BioHorizons Inc、Nobel Biocare Services AG、UBGEN、B&B Dental Implant Company、Botiss Biomaterials GmbH、Envista Holdings Corporation、ZVie Inc Holdings、Dentsply Sir
The Europe Regenerative Dentistry market was valued at US$ 836.50 million in 2024 and is projected to reach US$ 1,269.60 million by 2031; it is expected to register a CAGR of 6.3% during 2025-2031.The Europe Regenerative Dentistry market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. The increasing prevalence of dental disorders in aging population and increasing demand for cosmetic dentistry are the key factors propelling the Europe Regenerative Dentistry Market growth.
Increased Adoption of Tissue Regeneration
Stem cell therapy transforms how dental professionals approach tooth and tissue regeneration, especially for patients with substantial dental damage, tooth loss, or periodontal disease. Below are a few approaches that are likely to bring in new trends in the market:
Tooth Regeneration and Pulp Therapy:
Pulp therapy, particularly vital pulp therapy (VPT), is a critical component of restorative dentistry aimed at preserving the vitality of affected teeth. In Europe, the teaching and application of pulp therapy techniques vary: As per the PubMed, A survey of European dental schools revealed that 92.9% taught the use of ferric sulphate for vital pulpotomy in primary molars, indicating a preference for this material in educational settings. Success rates for VPT in mature permanent teeth have been notable. As per the Springer Nature Limited 2025, retrospective study reported a 99% success rate using iRoot BP Plus for pulpotomy over a 12-24-month follow-up period, highlighting the effectiveness of contemporary materials in pulp therapy. Researchers are exploring stem cell therapies to regenerate damaged or lost tooth pulp, which is crucial for maintaining tooth vitality. In Italy, institutions like the Universita degli Studi di Milano are actively investigating the potential of dental pulp stem cells for regenerating pulp tissue and even re-growing functional teeth. This innovation could replace traditional methods such as root canals or tooth extractions, providing more natural solutions for patients.
Collaboration with Research Institutions:
As per the University College London 2025, Discoveries Centre for Regenerative and Precision Medicine initiative is a collaboration between University College London (UCL) and a consortium of Portuguese universities, including the University of Minho. Supported by a €15 million EU Horizon 2020 grant, the Centre focuses on accelerating clinical applications and fostering innovation in regenerative and precision medicine, with headquarters in Portugal and a supporting campus at UCL. Politecnico di Milano is one of the universities partnering with private dental companies to conduct clinical trials and further explore the applications of stem cells in tooth and tissue regeneration. This collaborative environment fosters the development of new therapies and encourages the integration of stem cell techniques into mainstream dental practice.
Clinical Implementation:
Several dental clinics in Italy have begun incorporating stem cell therapy into their practices. For instance, the Clinica Odontoiatrica Guglielmo Marconi in Bologna offers regenerative treatments that utilize stem cells as part of their approach to periodontal therapy. These clinics are at the forefront of implementing innovative treatments, providing patients with advanced options for managing their tooth and gum health.
Bone and Gum Regeneration:
Stem cells are also used to regenerate bone tissue in patients who have experienced bone loss due to aging, disease, or trauma, particularly dental implants. Utilizing stem cells for bone regeneration helps improve implant success rates, especially for patients with insufficient bone density. Clinics in Italy, including those in Milan and Rome, are incorporating stem cell-based bone grafts to promote the regrowth of bone around implants. Additionally, stem cell therapy shows promise for gum regeneration. In cases of severe periodontal disease, stem cells can be used to regenerate gum tissues, enhancing both the functionality and aesthetic appearance of the gums.
Factor Hampering Europe Contract Research Organization Market
The high cost of dental regeneration treatments is a significant barrier to the growth of the Italy regenerative dentistry market. These advanced procedures, which include stem cell therapies, tissue engineering, and techniques for tooth regeneration, tend to be expensive due to the sophisticated technology and expertise they require. As a result, many patients are discouraged by the steep costs, limiting the market's potential for expansion. The cost of dental regenerative treatments in Europe varies based on the specific procedure and the country where it's performed. Here's a breakdown of average costs:
The average cost of a dental implant in Italy ranges from US$ 1,100 to US$ 2,700, depending on the clinic and location. Regenerative treatments, such as bone grafting or stem cell therapy, can drive up expenses, sometimes reaching US$ 5,500-10,800 per procedure because of the advanced materials and techniques involved. Clinics offering these services, particularly in cities such as Milan and Rome, typically charge premium fees for regenerative dental work.
At the International Health Center in Milan, a dental implant may cost between US$ 2,200 and US$ 2,700, while regenerative procedures like stem cell therapy for tooth regeneration can exceed US$ 8,700 per treatment. Similarly, Studio Dentistico Cristina Santi in Campello sul Clitunno provides regenerative treatments with costs ranging from US$ 4,800 to US$ 9,700, depending on the complexity of the procedure.
The price for a single dental implant in Europe typically ranges between €1,100 and €2,180, depending on the country. In Hungary, Poland, and the Czech Republic, the cost is approximately €1,100. In Germany, it's around €1,700. In the United Kingdom, the average cost is about €2,180.
Comprehensive procedures like All-on-4 implants, which replace all teeth in a jaw, can range from €4,000 to €18,000. The total cost depends on factors such as the number of implants and the materials used.
The cost of PRP therapy varies widely, typically ranging from $500 to $2,500 per injection, depending on various factors.
Stem cell therapy costs can vary significantly, ranging from $5,000 to $50,000, depending on factors such as the type of stem cells administered, the number of cells, the quality of the cells, the location of the laboratory, and the source of the stem cells.
These costs can be prohibitive for many patients, leading some to seek more affordable treatment options abroad. For instance, dental implants in Turkey can start at €500, offering significant savings compared to prices in Western Europe. The high expense of these treatments creates several barriers to their widespread adoption. Many patients struggle to afford such procedures, especially without comprehensive insurance coverage. Additionally, dental practitioners may be reluctant to invest in costly regenerative technologies without a clear return on investment, which further restricts the adoption of advanced techniques in many clinics and limits the growth of the regenerative dentistry market in Italy. Thus, while dental regenerative treatments hold great promise, the high costs associated with these procedures remain a significant obstacle to their accessibility and market expansion in Europe.
Based on product type, the Europe regenerative dentistry market is bifurcated into natural biomaterials and synthetic biomaterials. The natural biomaterials segment held a larger share of the Europe regenerative dentistry market in 2024.
By technology, the Europe regenerative dentistry market is segmented into tissue engineering, stem cell therapy, and others The tissue engineering segment held the largest share of the Europe regenerative dentistry market in 2024.
In terms of application, the Europe regenerative dentistry market is segmented into periodontal regeneration, endodontic regeneration, tooth reconstruction, bone regeneration, and others. The periodontal regeneration segment held the largest share in the Europe regenerative dentistry market in 2024.
By age group, the market is bifurcated into pediatric and adults. The adult segment held a larger share of the Europe regenerative dentistry market in 2024.
Based on end user, the market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the Europe regenerative dentistry market in 2024.
A few of the major primary and secondary sources referred to while preparing the report on the Europe Regenerative Dentistry Market are Geistlich Pharma AG, Evonik Industries AG, BioHorizons Inc, Nobel Biocare Services AG, UBGEN, B&B Dental Implant Company, Botiss Biomaterials GmbH, Envista Holdings Corporation, ZimVie Inc, Dentsply Sirona Inc